US$ 21.36
fda compounding semaglutide enforcement news today 2025 is moving to restrict mass-marketed compounded GLP-1 products that aren't FDA-approved, warning companies they can't market them as equivalent to approved drugs and signaling stronger to protect patients from unverified Compounded weight loss drugs get
Description
BCBS Michigan cites concerns about safety, effectiveness, and cost for this decision

And smart patent navigation
With GlucoVantage (Bioactive Berberine), probiotics, and colostrum, we're addressing the common side effects of GLP-1 medications to help individuals feel their best on their weight management journey

Long half-life (~6 days)
